Sphingolipids in prostate cancer prognosis: integrating single-cell and bulk sequencing.

This study contributes to our understanding of the role of sphingolipid metabolism in prostate cancer diagnosis and treatment. The identified prognostic model holds promise for improving risk stratification and patient outcomes in clinical settings.